Global Self Injection Device

Self Injection Device Comprehensive Study by Type (Reusable, Disposable), Application (Cancer, Auto-Immune Diseases, Hormonal Disorders, Pain Management, Others), Product Type (Pen Injectors, Auto-injectors, Wearable Injectors, Needle-Free Injectors) Players and Region - Global Market Outlook to 2027

Self Injection Device Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Self Injection Device?
Patients who require regular doses of medicine and hormones for long-term management of illnesses and diseases such as diabetes and rheumatoid arthritis benefit from self-injection devices. Self-injection Devices are available in both reusable and disposable versions. Self-injection Devices have benefits such as less hospital visits, ease of use, and low cost. Patients with chronic conditions can take control of their treatment schedule and treatment setting with self-injection devices, giving them more independence and freedom in their social, personal, and professional lives. Self-injection may also provide psychological advantages over professional administration, such as greater self-esteem. Removing the need for regular injections at a clinic or hospital also saves money for both the patient and the healthcare system. This economic gain has been the primary driver of market growth.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBecton (United States), Sensile Medical AG. (Switzerland), Owen Mumford Ltd. (United Kingdom), SHL Group (Switzerland), Wilhelm Haselmeier GmbH & Co. KG. (Germany), Dickinson and Company (United States), West Pharmaceutical Services (United States), Gerresheimer AG (Germany), Insulet Corporation (United States) and Ypsomed AG (Switzerland)
CAGR%


The market study is broken down by Type (Reusable and Disposable), by Application (Cancer, Auto-Immune Diseases, Hormonal Disorders, Pain Management and Others) and major geographies with country level break-up.

The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Self Injection Device market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Becton (United States), Sensile Medical AG. (Switzerland), Owen Mumford Ltd. (United Kingdom), SHL Group (Switzerland), Wilhelm Haselmeier GmbH & Co. KG. (Germany), Dickinson and Company (United States), West Pharmaceutical Services (United States), Gerresheimer AG (Germany), Insulet Corporation (United States) and Ypsomed AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Antares Pharma, Inc. (United States) and Consort Medical plc. (United Kingdom).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Self Injection Device market by Type, Application and Region.

On the basis of geography, the market of Self Injection Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product Type, the sub-segment i.e. Pen Injectors will boost the Self Injection Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In December 2021 - NuGen Medical Devices Company announce the launch of a needle-free injection system in Canada. They got approval from Health Canada for its needle-free injection system and accessories, also known as InsuJet.


Market Trend
  • Technological Advancements In Self-Injection Devices
  • Growing Demand For Auto-Injectors And Wearable Injectors

Market Drivers
  • High Prevalence And Incidence Rates Of Chronic Disorders
  • Increase In Demand For Biosimilar Drugs

Opportunities
  • Increasing Population Suffering From Autoimmune Disorders Across The Globe
  • Worldwide Increase In Diabetes And The Growing Pressure On Health Care Costs

Restraints
  • Strict Regulation For Patent Approval

Challenges
  • Lack Of Awareness Among The People In Underdeveloped And Developing Countries


Key Target Audience
Self Injection Device Manufacturers, Self Injection Device Distributors/Traders/Wholesalers, Self Injection Device Subcomponent Manufacturers, Industry Association and Downstream Vendors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Reusable
  • Disposable
By Application
  • Cancer
  • Auto-Immune Diseases
  • Hormonal Disorders
  • Pain Management
  • Others
By Product Type
  • Pen Injectors
  • Auto-injectors
  • Wearable Injectors
  • Needle-Free Injectors

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence And Incidence Rates Of Chronic Disorders
      • 3.2.2. Increase In Demand For Biosimilar Drugs
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Awareness Among The People In Underdeveloped And Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements In Self-Injection Devices
      • 3.4.2. Growing Demand For Auto-Injectors And Wearable Injectors
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Self Injection Device, by Type, Application, Product Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Self Injection Device (Value)
      • 5.2.1. Global Self Injection Device by: Type (Value)
        • 5.2.1.1. Reusable
        • 5.2.1.2. Disposable
      • 5.2.2. Global Self Injection Device by: Application (Value)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Auto-Immune Diseases
        • 5.2.2.3. Hormonal Disorders
        • 5.2.2.4. Pain Management
        • 5.2.2.5. Others
      • 5.2.3. Global Self Injection Device by: Type (Value)
        • 5.2.3.1. Reusable
        • 5.2.3.2. Disposable
      • 5.2.4. Global Self Injection Device by: Product Type (Value)
        • 5.2.4.1. Pen Injectors
        • 5.2.4.2. Auto-injectors
        • 5.2.4.3. Wearable Injectors
        • 5.2.4.4. Needle-Free Injectors
      • 5.2.5. Global Self Injection Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Self Injection Device (Price)
      • 5.3.1. Global Self Injection Device by: Type (Price)
  • 6. Self Injection Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sensile Medical AG. (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Owen Mumford Ltd. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. SHL Group (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Wilhelm Haselmeier GmbH & Co. KG. (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Dickinson and Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. West Pharmaceutical Services (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Gerresheimer AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Insulet Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ypsomed AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Self Injection Device Sale, by Type, Application, Product Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Self Injection Device (Value)
      • 7.2.1. Global Self Injection Device by: Type (Value)
        • 7.2.1.1. Reusable
        • 7.2.1.2. Disposable
      • 7.2.2. Global Self Injection Device by: Application (Value)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Auto-Immune Diseases
        • 7.2.2.3. Hormonal Disorders
        • 7.2.2.4. Pain Management
        • 7.2.2.5. Others
      • 7.2.3. Global Self Injection Device by: Type (Value)
        • 7.2.3.1. Reusable
        • 7.2.3.2. Disposable
      • 7.2.4. Global Self Injection Device by: Product Type (Value)
        • 7.2.4.1. Pen Injectors
        • 7.2.4.2. Auto-injectors
        • 7.2.4.3. Wearable Injectors
        • 7.2.4.4. Needle-Free Injectors
      • 7.2.5. Global Self Injection Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Self Injection Device (Price)
      • 7.3.1. Global Self Injection Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Self Injection Device: by Type(USD Million)
  • Table 2. Self Injection Device Reusable , by Region USD Million (2016-2021)
  • Table 3. Self Injection Device Disposable , by Region USD Million (2016-2021)
  • Table 4. Self Injection Device: by Application(USD Million)
  • Table 5. Self Injection Device Cancer , by Region USD Million (2016-2021)
  • Table 6. Self Injection Device Auto-Immune Diseases , by Region USD Million (2016-2021)
  • Table 7. Self Injection Device Hormonal Disorders , by Region USD Million (2016-2021)
  • Table 8. Self Injection Device Pain Management , by Region USD Million (2016-2021)
  • Table 9. Self Injection Device Others , by Region USD Million (2016-2021)
  • Table 10. Self Injection Device: by Type(USD Million)
  • Table 11. Self Injection Device Reusable , by Region USD Million (2016-2021)
  • Table 12. Self Injection Device Disposable , by Region USD Million (2016-2021)
  • Table 13. Self Injection Device: by Product Type(USD Million)
  • Table 14. Self Injection Device Pen Injectors , by Region USD Million (2016-2021)
  • Table 15. Self Injection Device Auto-injectors , by Region USD Million (2016-2021)
  • Table 16. Self Injection Device Wearable Injectors , by Region USD Million (2016-2021)
  • Table 17. Self Injection Device Needle-Free Injectors , by Region USD Million (2016-2021)
  • Table 18. South America Self Injection Device, by Country USD Million (2016-2021)
  • Table 19. South America Self Injection Device, by Type USD Million (2016-2021)
  • Table 20. South America Self Injection Device, by Application USD Million (2016-2021)
  • Table 21. South America Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 22. Brazil Self Injection Device, by Type USD Million (2016-2021)
  • Table 23. Brazil Self Injection Device, by Application USD Million (2016-2021)
  • Table 24. Brazil Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 25. Argentina Self Injection Device, by Type USD Million (2016-2021)
  • Table 26. Argentina Self Injection Device, by Application USD Million (2016-2021)
  • Table 27. Argentina Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 28. Rest of South America Self Injection Device, by Type USD Million (2016-2021)
  • Table 29. Rest of South America Self Injection Device, by Application USD Million (2016-2021)
  • Table 30. Rest of South America Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 31. Asia Pacific Self Injection Device, by Country USD Million (2016-2021)
  • Table 32. Asia Pacific Self Injection Device, by Type USD Million (2016-2021)
  • Table 33. Asia Pacific Self Injection Device, by Application USD Million (2016-2021)
  • Table 34. Asia Pacific Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 35. China Self Injection Device, by Type USD Million (2016-2021)
  • Table 36. China Self Injection Device, by Application USD Million (2016-2021)
  • Table 37. China Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 38. Japan Self Injection Device, by Type USD Million (2016-2021)
  • Table 39. Japan Self Injection Device, by Application USD Million (2016-2021)
  • Table 40. Japan Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 41. India Self Injection Device, by Type USD Million (2016-2021)
  • Table 42. India Self Injection Device, by Application USD Million (2016-2021)
  • Table 43. India Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 44. South Korea Self Injection Device, by Type USD Million (2016-2021)
  • Table 45. South Korea Self Injection Device, by Application USD Million (2016-2021)
  • Table 46. South Korea Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 47. Taiwan Self Injection Device, by Type USD Million (2016-2021)
  • Table 48. Taiwan Self Injection Device, by Application USD Million (2016-2021)
  • Table 49. Taiwan Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 50. Australia Self Injection Device, by Type USD Million (2016-2021)
  • Table 51. Australia Self Injection Device, by Application USD Million (2016-2021)
  • Table 52. Australia Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Self Injection Device, by Type USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Self Injection Device, by Application USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 56. Europe Self Injection Device, by Country USD Million (2016-2021)
  • Table 57. Europe Self Injection Device, by Type USD Million (2016-2021)
  • Table 58. Europe Self Injection Device, by Application USD Million (2016-2021)
  • Table 59. Europe Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 60. Germany Self Injection Device, by Type USD Million (2016-2021)
  • Table 61. Germany Self Injection Device, by Application USD Million (2016-2021)
  • Table 62. Germany Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 63. France Self Injection Device, by Type USD Million (2016-2021)
  • Table 64. France Self Injection Device, by Application USD Million (2016-2021)
  • Table 65. France Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 66. Italy Self Injection Device, by Type USD Million (2016-2021)
  • Table 67. Italy Self Injection Device, by Application USD Million (2016-2021)
  • Table 68. Italy Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 69. United Kingdom Self Injection Device, by Type USD Million (2016-2021)
  • Table 70. United Kingdom Self Injection Device, by Application USD Million (2016-2021)
  • Table 71. United Kingdom Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 72. Netherlands Self Injection Device, by Type USD Million (2016-2021)
  • Table 73. Netherlands Self Injection Device, by Application USD Million (2016-2021)
  • Table 74. Netherlands Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 75. Rest of Europe Self Injection Device, by Type USD Million (2016-2021)
  • Table 76. Rest of Europe Self Injection Device, by Application USD Million (2016-2021)
  • Table 77. Rest of Europe Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 78. MEA Self Injection Device, by Country USD Million (2016-2021)
  • Table 79. MEA Self Injection Device, by Type USD Million (2016-2021)
  • Table 80. MEA Self Injection Device, by Application USD Million (2016-2021)
  • Table 81. MEA Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 82. Middle East Self Injection Device, by Type USD Million (2016-2021)
  • Table 83. Middle East Self Injection Device, by Application USD Million (2016-2021)
  • Table 84. Middle East Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 85. Africa Self Injection Device, by Type USD Million (2016-2021)
  • Table 86. Africa Self Injection Device, by Application USD Million (2016-2021)
  • Table 87. Africa Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 88. North America Self Injection Device, by Country USD Million (2016-2021)
  • Table 89. North America Self Injection Device, by Type USD Million (2016-2021)
  • Table 90. North America Self Injection Device, by Application USD Million (2016-2021)
  • Table 91. North America Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 92. United States Self Injection Device, by Type USD Million (2016-2021)
  • Table 93. United States Self Injection Device, by Application USD Million (2016-2021)
  • Table 94. United States Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 95. Canada Self Injection Device, by Type USD Million (2016-2021)
  • Table 96. Canada Self Injection Device, by Application USD Million (2016-2021)
  • Table 97. Canada Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 98. Mexico Self Injection Device, by Type USD Million (2016-2021)
  • Table 99. Mexico Self Injection Device, by Application USD Million (2016-2021)
  • Table 100. Mexico Self Injection Device, by Product Type USD Million (2016-2021)
  • Table 101. Self Injection Device: by Type(USD/Units)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Self Injection Device: by Type(USD Million)
  • Table 113. Self Injection Device Reusable , by Region USD Million (2022-2027)
  • Table 114. Self Injection Device Disposable , by Region USD Million (2022-2027)
  • Table 115. Self Injection Device: by Application(USD Million)
  • Table 116. Self Injection Device Cancer , by Region USD Million (2022-2027)
  • Table 117. Self Injection Device Auto-Immune Diseases , by Region USD Million (2022-2027)
  • Table 118. Self Injection Device Hormonal Disorders , by Region USD Million (2022-2027)
  • Table 119. Self Injection Device Pain Management , by Region USD Million (2022-2027)
  • Table 120. Self Injection Device Others , by Region USD Million (2022-2027)
  • Table 121. Self Injection Device: by Type(USD Million)
  • Table 122. Self Injection Device Reusable , by Region USD Million (2022-2027)
  • Table 123. Self Injection Device Disposable , by Region USD Million (2022-2027)
  • Table 124. Self Injection Device: by Product Type(USD Million)
  • Table 125. Self Injection Device Pen Injectors , by Region USD Million (2022-2027)
  • Table 126. Self Injection Device Auto-injectors , by Region USD Million (2022-2027)
  • Table 127. Self Injection Device Wearable Injectors , by Region USD Million (2022-2027)
  • Table 128. Self Injection Device Needle-Free Injectors , by Region USD Million (2022-2027)
  • Table 129. South America Self Injection Device, by Country USD Million (2022-2027)
  • Table 130. South America Self Injection Device, by Type USD Million (2022-2027)
  • Table 131. South America Self Injection Device, by Application USD Million (2022-2027)
  • Table 132. South America Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 133. Brazil Self Injection Device, by Type USD Million (2022-2027)
  • Table 134. Brazil Self Injection Device, by Application USD Million (2022-2027)
  • Table 135. Brazil Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 136. Argentina Self Injection Device, by Type USD Million (2022-2027)
  • Table 137. Argentina Self Injection Device, by Application USD Million (2022-2027)
  • Table 138. Argentina Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 139. Rest of South America Self Injection Device, by Type USD Million (2022-2027)
  • Table 140. Rest of South America Self Injection Device, by Application USD Million (2022-2027)
  • Table 141. Rest of South America Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 142. Asia Pacific Self Injection Device, by Country USD Million (2022-2027)
  • Table 143. Asia Pacific Self Injection Device, by Type USD Million (2022-2027)
  • Table 144. Asia Pacific Self Injection Device, by Application USD Million (2022-2027)
  • Table 145. Asia Pacific Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 146. China Self Injection Device, by Type USD Million (2022-2027)
  • Table 147. China Self Injection Device, by Application USD Million (2022-2027)
  • Table 148. China Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 149. Japan Self Injection Device, by Type USD Million (2022-2027)
  • Table 150. Japan Self Injection Device, by Application USD Million (2022-2027)
  • Table 151. Japan Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 152. India Self Injection Device, by Type USD Million (2022-2027)
  • Table 153. India Self Injection Device, by Application USD Million (2022-2027)
  • Table 154. India Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 155. South Korea Self Injection Device, by Type USD Million (2022-2027)
  • Table 156. South Korea Self Injection Device, by Application USD Million (2022-2027)
  • Table 157. South Korea Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 158. Taiwan Self Injection Device, by Type USD Million (2022-2027)
  • Table 159. Taiwan Self Injection Device, by Application USD Million (2022-2027)
  • Table 160. Taiwan Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 161. Australia Self Injection Device, by Type USD Million (2022-2027)
  • Table 162. Australia Self Injection Device, by Application USD Million (2022-2027)
  • Table 163. Australia Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 164. Rest of Asia-Pacific Self Injection Device, by Type USD Million (2022-2027)
  • Table 165. Rest of Asia-Pacific Self Injection Device, by Application USD Million (2022-2027)
  • Table 166. Rest of Asia-Pacific Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 167. Europe Self Injection Device, by Country USD Million (2022-2027)
  • Table 168. Europe Self Injection Device, by Type USD Million (2022-2027)
  • Table 169. Europe Self Injection Device, by Application USD Million (2022-2027)
  • Table 170. Europe Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 171. Germany Self Injection Device, by Type USD Million (2022-2027)
  • Table 172. Germany Self Injection Device, by Application USD Million (2022-2027)
  • Table 173. Germany Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 174. France Self Injection Device, by Type USD Million (2022-2027)
  • Table 175. France Self Injection Device, by Application USD Million (2022-2027)
  • Table 176. France Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 177. Italy Self Injection Device, by Type USD Million (2022-2027)
  • Table 178. Italy Self Injection Device, by Application USD Million (2022-2027)
  • Table 179. Italy Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 180. United Kingdom Self Injection Device, by Type USD Million (2022-2027)
  • Table 181. United Kingdom Self Injection Device, by Application USD Million (2022-2027)
  • Table 182. United Kingdom Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 183. Netherlands Self Injection Device, by Type USD Million (2022-2027)
  • Table 184. Netherlands Self Injection Device, by Application USD Million (2022-2027)
  • Table 185. Netherlands Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 186. Rest of Europe Self Injection Device, by Type USD Million (2022-2027)
  • Table 187. Rest of Europe Self Injection Device, by Application USD Million (2022-2027)
  • Table 188. Rest of Europe Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 189. MEA Self Injection Device, by Country USD Million (2022-2027)
  • Table 190. MEA Self Injection Device, by Type USD Million (2022-2027)
  • Table 191. MEA Self Injection Device, by Application USD Million (2022-2027)
  • Table 192. MEA Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 193. Middle East Self Injection Device, by Type USD Million (2022-2027)
  • Table 194. Middle East Self Injection Device, by Application USD Million (2022-2027)
  • Table 195. Middle East Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 196. Africa Self Injection Device, by Type USD Million (2022-2027)
  • Table 197. Africa Self Injection Device, by Application USD Million (2022-2027)
  • Table 198. Africa Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 199. North America Self Injection Device, by Country USD Million (2022-2027)
  • Table 200. North America Self Injection Device, by Type USD Million (2022-2027)
  • Table 201. North America Self Injection Device, by Application USD Million (2022-2027)
  • Table 202. North America Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 203. United States Self Injection Device, by Type USD Million (2022-2027)
  • Table 204. United States Self Injection Device, by Application USD Million (2022-2027)
  • Table 205. United States Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 206. Canada Self Injection Device, by Type USD Million (2022-2027)
  • Table 207. Canada Self Injection Device, by Application USD Million (2022-2027)
  • Table 208. Canada Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 209. Mexico Self Injection Device, by Type USD Million (2022-2027)
  • Table 210. Mexico Self Injection Device, by Application USD Million (2022-2027)
  • Table 211. Mexico Self Injection Device, by Product Type USD Million (2022-2027)
  • Table 212. Self Injection Device: by Type(USD/Units)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Self Injection Device: by Type USD Million (2016-2021)
  • Figure 5. Global Self Injection Device: by Application USD Million (2016-2021)
  • Figure 6. Global Self Injection Device: by Type USD Million (2016-2021)
  • Figure 7. Global Self Injection Device: by Product Type USD Million (2016-2021)
  • Figure 8. South America Self Injection Device Share (%), by Country
  • Figure 9. Asia Pacific Self Injection Device Share (%), by Country
  • Figure 10. Europe Self Injection Device Share (%), by Country
  • Figure 11. MEA Self Injection Device Share (%), by Country
  • Figure 12. North America Self Injection Device Share (%), by Country
  • Figure 13. Global Self Injection Device: by Type USD/Units (2016-2021)
  • Figure 14. Global Self Injection Device share by Players 2021 (%)
  • Figure 15. Global Self Injection Device share by Players (Top 3) 2021(%)
  • Figure 16. Global Self Injection Device share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Becton (United States) Revenue, Net Income and Gross profit
  • Figure 19. Becton (United States) Revenue: by Geography 2021
  • Figure 20. Sensile Medical AG. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Sensile Medical AG. (Switzerland) Revenue: by Geography 2021
  • Figure 22. Owen Mumford Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Owen Mumford Ltd. (United Kingdom) Revenue: by Geography 2021
  • Figure 24. SHL Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. SHL Group (Switzerland) Revenue: by Geography 2021
  • Figure 26. Wilhelm Haselmeier GmbH & Co. KG. (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Wilhelm Haselmeier GmbH & Co. KG. (Germany) Revenue: by Geography 2021
  • Figure 28. Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Dickinson and Company (United States) Revenue: by Geography 2021
  • Figure 30. West Pharmaceutical Services (United States) Revenue, Net Income and Gross profit
  • Figure 31. West Pharmaceutical Services (United States) Revenue: by Geography 2021
  • Figure 32. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. Gerresheimer AG (Germany) Revenue: by Geography 2021
  • Figure 34. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. Insulet Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Ypsomed AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Ypsomed AG (Switzerland) Revenue: by Geography 2021
  • Figure 38. Global Self Injection Device: by Type USD Million (2022-2027)
  • Figure 39. Global Self Injection Device: by Application USD Million (2022-2027)
  • Figure 40. Global Self Injection Device: by Type USD Million (2022-2027)
  • Figure 41. Global Self Injection Device: by Product Type USD Million (2022-2027)
  • Figure 42. South America Self Injection Device Share (%), by Country
  • Figure 43. Asia Pacific Self Injection Device Share (%), by Country
  • Figure 44. Europe Self Injection Device Share (%), by Country
  • Figure 45. MEA Self Injection Device Share (%), by Country
  • Figure 46. North America Self Injection Device Share (%), by Country
  • Figure 47. Global Self Injection Device: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Becton (United States)
  • Sensile Medical AG. (Switzerland)
  • Owen Mumford Ltd. (United Kingdom)
  • SHL Group (Switzerland)
  • Wilhelm Haselmeier GmbH & Co. KG. (Germany)
  • Dickinson and Company (United States)
  • West Pharmaceutical Services (United States)
  • Gerresheimer AG (Germany)
  • Insulet Corporation (United States)
  • Ypsomed AG (Switzerland)
Additional players considered in the study are as follows:
Antares Pharma, Inc. (United States) , Consort Medical plc. (United Kingdom)
Select User Access Type

Key Highlights of Report


May 2022 248 Pages 79 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Self Injection Device Quantitative research analysis
Global Self Injection Device Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Becton (United States), Sensile Medical AG. (Switzerland), Owen Mumford Ltd. (United Kingdom), SHL Group (Switzerland), Wilhelm Haselmeier GmbH & Co. KG. (Germany), Dickinson and Company (United States), West Pharmaceutical Services (United States), Gerresheimer AG (Germany), Insulet Corporation (United States) and Ypsomed AG (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
Analysts at AMA estimates Self Injection Device Market to reach USD Million by 2027.

Know More About Global Self Injection Device Report?

Have a Query? Click Here

Other Related Reports

Coated Endotracheal Tube Comprehensive Study by Application (Anesthesia, Emergency Medicine, Others), Intubation (Orotracheal Intubation, Nasotracheal Intubation), End User (Hospital, Clinics, Ambula...
$ 3350
Adult Ventilators Comprehensive Study by Type (Intensive Care Ventilators (High-end ICU Ventilators, Mid-end ICU Ventilators, Basic ICU Ventilators), Portable/Transportable Ventilators), Application ...
$ 3750
Imaging Diagnostic Catheters Comprehensive Study by Type (Angiography Catheters, Electrophysiology Catheters (Conventional Electrophysiology Catheters, Advanced Electrophysiology Catheters), Non-Imag...
$ 3750
Medication Telemanagement Devices Comprehensive Study by Type (Inhalers, Pill Boxes, Insulin Pumps, Other), Application (Hospitals, Pharmacies, Other Healthcare Institutions), Services (Medication An...
$ 3750
Shadowless Lamps Comprehensive Study by Type (LED Operation, Multi-Level Focus, Single Reflection), Application (Hospital, Clinic, Other), Distribution Channel (Online, Offline), Technology (Halogen-...
$ 3450
Veterinary Surgical Sutures Comprehensive Study by Type (Absorbable (Plain Gut, Chromic Gut, Vet. CRYL Polyglactin, Vet. SORB - Polyglycolic Acid, Vet. DIOX – Polydioxanone, Vet. CAPRONE – Polyglecap...
$ 3750